rewirebio.iobenchmarks
Configuration

ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)

ClairS-TO SS v0.4.0, tumour-only, ONT: Model trained on synthetic tumours only (GIAB HG001/HG002 for ONT; HG003/HG004 for PacBio and Illumina); default panels of normals (gnomAD r2.1, dbSNP v138, 1000 Genomes PoN, CoLoRSdb) and hard filters; short-read runs omit long-read-specific filters.

4 evaluations · 84 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

4 evaluations · 84 results. Different protocols are not a single leaderboard.

Sorted by AUPRC (indel only, tumour-only, 25x tumour coverage) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetAUPRC (indel only, tumour-only, 25x tumour coverage)AUPRC (indel only, tumour-only, 50x tumour coverage)AUPRC (indel only, tumour-only, 75x tumour coverage)AUPRC (SNV only, tumour-only, 25x tumour coverage)AUPRC (SNV only, tumour-only, 50x tumour coverage)AUPRC (SNV only, tumour-only, 75x tumour coverage)F1 (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)F1 (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)F1 (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)F1 (SNV only, tumour-only, 25x tumour coverage, at the best-F1 threshold)F1 (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)F1 (SNV only, tumour-only, 75x tumour coverage, at the best-F1 threshold)False negatives (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)False negatives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False negatives (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)False negatives (SNV only, tumour-only, 25x tumour coverage, at the best-F1 threshold)False negatives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False negatives (SNV only, tumour-only, 75x tumour coverage, at the best-F1 threshold)False positives (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)False positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False positives (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)False positives (SNV only, tumour-only, 25x tumour coverage, at the best-F1 threshold)False positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False positives (SNV only, tumour-only, 75x tumour coverage, at the best-F1 threshold)Precision (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)Precision (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Precision (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)Precision (SNV only, tumour-only, 25x tumour coverage, at the best-F1 threshold)Precision (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Precision (SNV only, tumour-only, 75x tumour coverage, at the best-F1 threshold)Recall (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)Recall (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Recall (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)Recall (SNV only, tumour-only, 25x tumour coverage, at the best-F1 threshold)Recall (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Recall (SNV only, tumour-only, 75x tumour coverage, at the best-F1 threshold)True positives (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)True positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)True positives (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)True positives (SNV only, tumour-only, 25x tumour coverage, at the best-F1 threshold)True positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)True positives (SNV only, tumour-only, 75x tumour coverage, at the best-F1 threshold)
ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)EvaluationONT HCC1395 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2b), HCC1395 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)0.407 (best in column)0.416 (best in column)0.434 (best in column)Not reportedNot reportedNot reported0.448 (best in column)0.512 (best in column)0.533 (best in column)Not reportedNot reportedNot reported826463433Not reportedNot reportedNot reported479 (best in column)1,2411,185Not reportedNot reportedNot reported0.525 (best in column)0.418 (best in column)0.438 (best in column)Not reportedNot reportedNot reported0.3910.659 (best in column)0.681 (best in column)Not reportedNot reportedNot reported530 (best in column)893 (best in column)923 (best in column)Not reportedNot reportedNot reported
ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)EvaluationONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a), COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)0.1670.1830.186Not reportedNot reportedNot reported0.2670.280.28Not reportedNot reportedNot reported305 (best in column)299 (best in column)300 (best in column)Not reportedNot reportedNot reported1,2341,171 (best in column)1,168 (best in column)Not reportedNot reportedNot reported0.1850.1960.196Not reportedNot reportedNot reported0.479 (best in column)0.4890.487Not reportedNot reportedNot reported280286285Not reportedNot reportedNot reported
ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)EvaluationONT COLO829 tumour-only, 25x to 75x, somatic SNVs (Chen et al. 2025 Supplementary Table 2a), COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)Not reportedNot reportedNot reported0.615 (best in column)0.618 (best in column)0.619 (best in column)Not reportedNot reportedNot reported0.763 (best in column)0.7640.763Not reportedNot reportedNot reported3,245 (best in column)2,696 (best in column)2,723Not reportedNot reportedNot reported18,01518,87018,951Not reportedNot reportedNot reported0.6560.6490.647Not reportedNot reportedNot reported0.913 (best in column)0.928 (best in column)0.927 (best in column)Not reportedNot reportedNot reported34,288 (best in column)34,837 (best in column)34,810 (best in column)
ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)EvaluationONT HCC1395 tumour-only, 25x to 75x, somatic SNVs (Chen et al. 2025 Supplementary Table 2b), HCC1395 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)Not reportedNot reportedNot reported0.5690.5860.59Not reportedNot reportedNot reported0.7630.793 (best in column)0.797 (best in column)Not reportedNot reportedNot reported4,7133,0082,478 (best in column)Not reportedNot reportedNot reported12,371 (best in column)12,239 (best in column)12,663 (best in column)Not reportedNot reportedNot reported0.69 (best in column)0.705 (best in column)0.701 (best in column)Not reportedNot reportedNot reported0.8540.9070.923Not reportedNot reportedNot reported27,49929,20429,734
All 84 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.167 AUPRC (indel only, tumour-only, 25x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'Indel', column 'AUPRC'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.267 F1 (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'Indel', column 'F1-score'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
305 False negatives (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'Indel', column 'FN'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
1,234 False positives (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'Indel', column 'FP'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.185 Precision (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'Indel', column 'Precision'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.479 Recall (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'Indel', column 'Recall'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
280 True positives (indel only, tumour-only, 25x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'Indel', column 'TP'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.183 AUPRC (indel only, tumour-only, 50x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'AUPRC'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.28 F1 (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'F1-score'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
299 False negatives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'FN'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
1,171 False positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'FP'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.196 Precision (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'Precision'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.489 Recall (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'Recall'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
286 True positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '50x', Type 'Indel', column 'TP'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.186 AUPRC (indel only, tumour-only, 75x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '75x', Type 'Indel', column 'AUPRC'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.28 F1 (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '75x', Type 'Indel', column 'F1-score'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
300 False negatives (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '75x', Type 'Indel', column 'FN'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
1,168 False positives (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '75x', Type 'Indel', column 'FP'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.196 Precision (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '75x', Type 'Indel', column 'Precision'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.487 Recall (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '75x', Type 'Indel', column 'Recall'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic indels (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
285 True positives (indel only, tumour-only, 75x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '75x', Type 'Indel', column 'TP'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic SNVs (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.615 AUPRC (SNV only, tumour-only, 25x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'SNV', column 'AUPRC'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic SNVs (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
0.763 F1 (SNV only, tumour-only, 25x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'SNV', column 'F1-score'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic SNVs (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
3,245 False negatives (SNV only, tumour-only, 25x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'SNV', column 'FN'
Configuration: ClairS-TO SS v0.4.0, tumour-only, ONT (Chen et al. 2025)Protocol: ONT COLO829 tumour-only, 25x to 75x, somatic SNVs (Chen et al. 2025 Supplementary Table 2a)
Dataset: COLO829 tumour ONT R10.4.1 WGS (ClairS-TO benchmark)
18,015 False positives (SNV only, tumour-only, 25x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClairS-TO SS on ont-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-ont-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 2a, Dataset 'COLO829', Caller 'ClairS-TO SS', Tumor coverage '25x', Type 'SNV', column 'FP'

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Use this configuration

How it works, versions and access
Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

3 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: somatic-clairs-to-20261011-config-clairs-to-ss-ont

areas
dna-genomes
contexts
clinical_research
method types
supervised_machine_learning
reported name
ClairS-TO SS
version
v0.4.0
foundation model eligible
false
parameters
Model trained on synthetic tumours only (GIAB HG001/HG002 for ONT; HG003/HG004 for PacBio and Illumina); default panels of normals (gnomAD r2.1, dbSNP v138, 1000 Genomes PoN, CoLoRSdb) and hard filters; short-read runs omit long-read-specific filters
access reuse
Public open-source software and released models
source locator
Supplementary Information 'Command lines used'; Supplementary Tables 2 and 7 row labels
provenance note
ClairS-TO SS as run on ONT tumour-only data in the cited comparison.
Related records

Suggest a correction